Hide metadata

dc.date.accessioned2020-12-10T18:56:34Z
dc.date.available2020-12-10T18:56:34Z
dc.date.created2020-12-03T12:05:12Z
dc.date.issued2020
dc.identifier.citationVetyskova, Veronika Zouharova, Monika Bednarova, Lucie Vaněk, Ondřej Sázelová, Petra Kašička, Václav Vymetal, Jiri Srp, Jaroslav Rumlová, Michaela Charnavets, Tatsiana Postulkova, Klara Reseland, Janne Elin Bousova, Kristyna Vondrasek, Jiri . Characterization of AMBN I and II isoforms and study of their Ca2+ binding properties. International Journal of Molecular Sciences. 2020, 21, 9293
dc.identifier.urihttp://hdl.handle.net/10852/81567
dc.description.abstractAmeloblastin (Ambn) as an intrinsically disordered protein (IDP) stands for an important role in the formation of enamel—the hardest biomineralized tissue commonly formed in vertebrates. The human ameloblastin (AMBN) is expressed in two isoforms: full-length isoform I (AMBN ISO I) and isoform II (AMBN ISO II), which is about 15 amino acid residues shorter than AMBN ISO I. The significant feature of AMBN—its oligomerization ability—is enabled due to a specific sequence encoded by exon 5 present at the N-terminal part in both known isoforms. In this study, we characterized AMBN ISO I and AMBN ISO II by biochemical and biophysical methods to determine their common features and differences. We confirmed that both AMBN ISO I and AMBN ISO II form oligomers in in vitro conditions. Due to an important role of AMBN in biomineralization, we further addressed the calcium (Ca2+)-binding properties of AMBN ISO I and ISO II. The binding properties of AMBN to Ca2+ may explain the role of AMBN in biomineralization and more generally in Ca2+ homeostasis processes.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleCharacterization of AMBN I and II isoforms and study of their Ca2+ binding properties
dc.typeJournal article
dc.creator.authorVetyskova, Veronika
dc.creator.authorZouharova, Monika
dc.creator.authorBednarova, Lucie
dc.creator.authorVaněk, Ondřej
dc.creator.authorSázelová, Petra
dc.creator.authorKašička, Václav
dc.creator.authorVymetal, Jiri
dc.creator.authorSrp, Jaroslav
dc.creator.authorRumlová, Michaela
dc.creator.authorCharnavets, Tatsiana
dc.creator.authorPostulkova, Klara
dc.creator.authorReseland, Janne Elin
dc.creator.authorBousova, Kristyna
dc.creator.authorVondrasek, Jiri
cristin.unitcode185,16,17,7
cristin.unitnameKlinisk forskningslaboratorium
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1855772
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International Journal of Molecular Sciences&rft.volume=21&rft.spage=9293&rft.date=2020
dc.identifier.jtitleInternational Journal of Molecular Sciences
dc.identifier.volume21
dc.identifier.issue23
dc.identifier.doihttps://doi.org/10.3390/ijms21239293
dc.identifier.urnURN:NBN:no-84649
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1422-0067
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/81567/1/ijms-21-09293-v2.pdf
dc.type.versionPublishedVersion
cristin.articleid9293


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International